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INTRODUCTION
The association between diagonal earlobe crease (ELC) and
cardiovascular diseases (CVD) was first reported in 1973 [1].
Subsequently, several studies have found a significant associ-
ation between the presence of ELC and CVD [2, 3]. Moreover,
it has been reported [4] that the association between ELC and
carotid intima-media thickness (IMT), which is widely used
as a surrogate marker for atherosclerotic disease, has been
shown to predict the incidence of CVD events [5-7] and has
been associated with cardiovascular risk factors [8, 9].
Atherosclerosis is an essential process in the development
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of major cardiovascular and cerebrovascular events. Charac-
teristic changes of atherosclerosis include stiffness, thickness,
and inflammation of arterial walls [10, 11]. Therefore, early
detection of functional, structural, and biochemical arterial wall
changes may identify patients at high risk of clinical complica-
tions from atherosclerosis. Pulse wave velocity (PWV) is the
most widely used measure of arterial stiffness in a wide vari-
ety of clinical fields [12]. Recently, approaches to measuring
arterial stiffness including that of the aorta, which passes over
the lower limb arteries, have been of interest [13]. Brachial-
ankle PWV (baPWV) is a non-invasive and useful measure of
arterial stiffness [14, 15] whose physiological characteristics
are closer to those of carotid-femoral PWV than of femoral-
ankle PWV [16]. The reproducibility of this measure has been
validated [14, 15]. Recent data has demonstrated that higher
baPWV is associated with more advanced atherosclerotic ch-
anges of the arterial wall in clinical patients [16, 17] and sub-
clinical individuals [18, 19]. However, no previous study has
investigated the relationship between the presence of ELC
and baPWV. In this cross-sectional study, we examined the
association between ELC and baPWV in Korean adults in a
health examination programme.
MATERIALS AND METHODS
Study subjects
The present study was designed as a cross-sectional study.
A total of 852 adults aged 20-80 yr who had a regular physi-
cal health examination (including a baPWV measurement) at
the Health Promotion Center of Severance Hospital in Seoul
from November 2007 to March 2008 were invited to partic-
ipate. Of the total subjects recruited for the study, 279 were
excluded from the analysis; for 32 the diagnosis of ELC was
not clear, 16 had self-reported CVD, 149 had hypertension,
28 had diabetes mellitus (DM), 31 did not precisely recall the
date of their last menstrual period or did not answer the ques-
tionnaire, and 23 had an ankle/brachial pressure index of less
than 0.9. In total, 573 subjects were enrolled in the present
study. CVD was defined by: 1) self-reported myocardial infarc-
tion, angina, or use of nitroglycerin; 2) self-reported history
of coronary angioplasty or coronary artery bypass surgery;
3) self-reported stroke, transient ischemic attack, or carotid
endarterectomy. Hypertension was defined as systolic blood
pressure (SBP) ≥140 mmHg and/or diastolic blood pressure
(DBP) ≥90 mmHg or using antihypertensive drugs. DM was
defined as fasting blood sugar ≥126 mg/dL and/or use of
pharmacological treatment. Hypertensive or diabetic subjects
were strictly excluded. The menopausal status of the women
involved in this study was confirmed by interview. Women
who had not menstruated in 12 months were considered to
be menopausal.
The presence of ELC was assigned to subjects with a crease
stretching obliquely from the outer ear canal towards the bor-
der of the earlobe without discontinuity. Unilateral or bilat-
eral earlobes were all considered to indicate the presence of
ELC. Those who have an earring or piercing or revealing in-
complete ELC patterns, in which a diagnosis of the ELC might
be confused, were not included from the analysis. The study
was approved by the Institutional Review Board at Severance
Hospital, Yonsei University College of Medicine in Seoul, Ko-
rea. Informed consent was received from the subjects.
Assessment of anthropometric and cardiometabolic
factors
While they were wearing light clothes and no shoes, the
height and weight of subjects were measured in units of 0.1
cm and 0.1 kg, respectively. Body mass index (BMI) was cal-
culated by dividing weight (kg) by the square of height (m),
according to the guidelines recommended by National Insti-
tutes of Health. Waist circumference (WC) was measured by
the same tester in units of 0.1 cm on the horizontal plane to
the surface directly above the iliac crest in the upright position.
A sample of fasting venous blood was taken for the measure-
ment of glucose, total cholesterol, high-density lipoprotein
(HDL) cholesterol and low-density lipoprotein (LDL) ch-
olesterol, and triglyceride. Serum biochemical parameters were
measured after at least 10 hr of fasting. The results from the
blood samples were analysed using a Hitachi-7600 (Hitachi
High-Technologies Co., Tokyo, Japan). 
Measurement of baPWV
In brief, baPWV was measured using an automatic wave-
form analyser model BP-203RPE (Colin Co., Komaki, Japan)
which was described in detail elsewhere [20]. This instrument
simultaneously records blood pressure, phonocardiogram, elec-
trocardiogram, and arterial blood pressure at both the left and
right brachial arteries as well as ankles. Subjects were exam-
ined in the supine position after 10 min of bed rest. Electro-
cardiogram electrodes were placed on both wrists and a
microphone for the phonogram was placed on the left edge
of the sternum. Pneumonic cuffs were wrapped around both
the upper arms and ankles and connected to a plethysmograph-
ic sensor to determine the volume pulse waveform. Waveforms
for the upper arm (brachial artery) and ankle (tibial artery)
were stored as 10 sec sample times with automatic gain anal-
ysis and quality adjustment. An oscillometric pressure sensor
was attached to the cuffs to measure blood pressure at the four
extremities. baPWV was recorded using a semiconductor pres-
sure sensor (1,200 Hz sample acquisition frequency) and cal-culated using the following equation: (La-Lb)/ Tba. La and
Lb were defined as the distance from the aortic valve to the
elbow and the distance from the aortic valve to the ankle, res-
pectively. The distance from the suprasternal notch to the elbow
(La) and from the suprasternal notch to the ankle (Lb) were
expressed as follows: La=0.2195*height (cm) of subject -2.0734
and Lb=0.8129*height (cm) of subject +12.328. The time inter-
val between arm and ankle distance ( Tba) was defined as
the pulse transit time between brachial and tibial arterial pres-
sure waveforms. La and Lb are estimated automatically based
on subjects’ height.
Statistical analysis
Continuous variables were expressed as mean±standard
deviation and categorical variables were expressed as percent-
ages. Subjects were divided into three groups according to gen-
der and menopausal status as follows; premenopausal and post-
menopausal women, and men. Comparison of categorical and
continuous variables between groups was performed using
Yates’ continuity corrected chi-square test and independent t-
test, respectively. Relationships between baPWV and variables
were assessed using linear regression analysis and Pearson’s
correlation coefficient. Multiple linear regression analysis was
performed to examine the independent relationship between
ELC and baPWV adjusting for age, BMI, WC, SBP, DBP, fast-
ing plasma glucose, total cholesterol, HDL and LDL cholesterol,
triglyceride, and smoking status. The statistical analysis was
performed using SAS Ver. 9.1 (SAS Inc., Cary, NC, USA).
RESULTS
Characteristics of the study subjects
The study subjects stratified according to gender and meno-
pausal status are presented in Table 1. The overall frequency
of ELC was 19.02% and mean baPWV was 1,401.98±172.28
cm/s of the subjects in this study.
Correlation between baPWV and variables examined
The correlation between baPWV and anthropometric and
cardiometabolic variables are shown in Table 2. baPWV were
significantly correlated with age, SBP, and DBP across three
groups. However, other variables including BMI, WC, triglyc-
eride, and HDL cholesterol were significantly correlated only
in the premenopausal women group, and fasting plasma glu-
cose was correlated only in the men and premenopausal women
group. The correlation with total cholesterol and smoking sta-
tus (pack per year) was not significant in any groups. The com-
parison of baPWV according to the presence of ELC is shown
in Table 3. There was a statistically significant difference in
mean baPWV with the presence of ELC in groups except for
postmenopausal women (1,522.20±196.07 vs 1,426.90±
3
Choi SI et al.: Association Between Earlobe Crease (ELC) and Brachial-ankle Pulse Wave Velocity (baPWV)
Age (yr) 50.98±9.23 51.19±8.45 43.03±10.65 56.54±6.02 0.4692 <0.0001
Earlobe crease (yes) 109 (19.02%) 87 (22.14%) 7 (8.75%) 15 (15%) 0.0071* 0.2969*
Body mass index (cm/m
2) 24.05±2.94 24.55±2.75 21.96±2.74 23.77±3.10 <0.0001 <0.0001
Waist circumference (cm) 81.63±8.72 84.26±7.57 72.81±7.96 78.31±7.78 <0.0001 <0.0001
Systolic blood pressure (mmHg) 117.65±12.68 119.12±11.81 110.18±11.64 117.83±14.67 <0.0001 0.0001
Diastolic blood pressure (mmHg) 76.16±10.54 77.99±10.16 69.64±8.76 74.16±10.93 <0.0001 0.0024
Fasting plasma glucose (mg/dL) 91.45±14.77 93.38±16.37 83.88±8.32 89.94±8.99 <0.0001 <0.0001
Total cholesterol (mg/dL) 202.35±31.63 202.68±31.41 193.03±30.69 208.50±31.82 0.7101 0.0011
Triglyceride (mg/dL) 140.50±74.52 155.37±78.66 92.59±40.42 120.40±56.02 <0.0001 0.0002
HDL cholesterol (mg/dL) 54.16±13.29 51.09±11.55 63.90±15.21 58.45±13.23 <0.0001 0.0124
LDL cholesterol (mg/dL) 124.62±28.01 126.42±27.68 112.38±28.62 127.34±26.54 0.0229 0.0004
Smoking status (pack year) 9.90±13.91 13.98±14.72 0.44±1.81 1.47±6.88 <0.0001 0.1549
FHx of cardio (yes) 72 (12.57%) 50 (12.72%) 12 (15%) 10 (10%) 0.9745* 0.4303*
baPWV (cm/s) 1401.98±172.28 1408.75±166.28 1319.69±170.58 1441.19±177.69 0.1647 <0.0001
Female Female Male Pre-
Total Male (premeno- (postmeno- vs menopausal vs
pause) pause) female postmenopausal
(N=573) (N=393) (N=80) (N=100) p value p value
Characteristic (unit)
Data are mean±standard deviation 
HDL, high-density lipoprotein; LDL, low-density lipoprotein; FHx of cardio, family history of premature coronary heart disease; baPWV, brachial-ankle
pulse wave velocity.
*Chi-square test with Yates’ continuity correction.
Table 1. Clinical and laboratory characteristics of study subjects171.55 cm/s, p=0.0551).
Relationship between ELC and baPWV
Multiple linear regression analysis of all the study groups
revealed that after controlling for age, BMI, WC, SBP, DBP,
fasting plasma glucose, triglyceride, HDL cholesterol, LDL
cholesterol, and smoking status, the presence of ELC was still
independently associated with baPWV (as shown in Table 4).
The significant relationship between ELC and baPWV was
demonstrated regardless of gender and menopausal status.
Subjects with ELC had significantly higher baPWV, which Data are mean±standard deviation.
baPWV, brachial-ankle pulse wave velocity.
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Male 1490.90±200.98 1385.40±147.22 <0.0001
Female 1550.00±259.15 1297.60±143.80 0.0419
(premenopause)
Female 1522.20±196.07 1426.90±171.55 0.0551
(postmenopause)
Earlobe crease
Present Absent
Group p value
Table 3. Comparisons between the presence of ELC and
baPWV according to gender
Main variable for exposure
Earlobe crease (yes) 81.50 (17.99)  <0.0001 123.67 (50.15) 0.0162  101.25 (42.99) 0.0208
Adjustment variables
Age (yr) 4.66 (0.88) <0.0001 6.93 (1.54) <0.0001 9.89 (2.67) 0.0004
Body mass index (kg/m
2) -14.32 (4.07) <0.0001 -19.90 (8.92) 0.0290  -20.46 (8.80) 0.0223
Waist circumference (cm) -1.09 (1.48) 0.7068  4.26 (3.33) 0.2046  1.60 (3.45) 0.6451
Systolic blood pressure (mmHg) 3.86 (0.95) <0.0001 7.59 (1.64) <0.0001 4.86 (1.59) 0.0030
Diastolic blood pressure (mmHg) 1.87 (1.07) 0.4496  -3.68 (2.11) 0.0852  1.55 (2.05) 0.4517
Fasting plasma glucose (mg/dL) 1.30 (0.43) 0.0026  1.25 (1.80) 0.4895  1.04 (1.70) 0.5396
Triglyceride (mg/dL) 0.29 (0.10) 0.0635  0.16 (0.43) 0.7154  -0.68 (0.27) 0.0130
HDL cholesterol (mg/dL) -0.46 (0.66) 0.1836  -0.39 (1.12) 0.7310  -1.21 (1.20) 0.3170
LDL cholesterol (mg/dL) 0.86 (0.26) 0.0004  -0.13 (0.52) 0.8064  1.02 (0.53) 0.0570
Smoking status (pack year) -0.44 (0.48) 0.3343  1.45 (7.63) 0.8503  -2.74 (2.10) 0.1949
R
2 (coefficient of determination) 0.3540 0.6071 0.4925
Male
Female Female
(premenopause) (postmenopause)
β (SE) p value β (SE) p value β (SE) p value
Variables (unit)
baPWV, brachial-ankle pulse wave velocity; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SE, standard error.
Table 4. Risk factors associated with baPWV analysed by multiple linear regression analysis
Age (years) 0.31  <0.0001 0.61  <0.0001 0.40  <0.0001
Body mass index (kg/m
2) -0.08 0.1233 0.24 0.0309 -0.03 0.7619
Waist circumference (cm) 0.03  0.5371  0.41  0.0002  0.03  0.7619
Systolic blood pressure (mmHg) 0.39  <0.0001 0.50  <0.0001 0.51  <0.0001
Diastolic blood pressure (mmHg) 0.35  <0.0001 0.22  0.0457  0.32  0.0010
Fasting plasma glucose (mg/dL) 0.20  <0.0001 0.33  0.0030  0.16  0.1079
Total cholesterol (mg/dL) 0.18  0.0003  0.07  0.5556  0.12  0.2400
Triglyceride (mg/dL) 0.09  0.0758  0.25  0.0257  -0.06 0.5350
HDL cholesterol (mg/dL) -0.05 0.3190 -0.31 0.0053 -0.07 0.5020
LDL cholesterol (mg/dL) 0.16  0.0013  0.18  0.1081  0.19  0.0538
Smoking status (pack year) -0.04 0.4744 0.01 0.9072 -0.14 0.1604 
Male
Female Female
(premenopause) (postmenopause)
r p value r p value r p value
Variables (unit)
Data are Pearson’s correlation coefficient (r).
HDL, high-density lipoprotein; LDL, low-density lipoprotein; baPWV, brachial-ankle pulse wave velocity.
Table 2. Simple correlation analysis between baPWV (cm/s) and other conventional atherosclerotic risk factorsestimated by the multiple regression equation, was compara-
ble to subjects without ELC. The comparison is shown in the
box plot in Figure 1.
DISCUSSION
The current study showed that the presence of ELC was
significantly associated with baPWV, independent of conven-
tional cardiovascular risk factors in a sample of adults free of
clinical event atherosclerotic diseases such as hypertension,
DM and other CVD. The present study indicates that the pres-
ence of ELC demonstrated a strong association with baPWV
independent of other variables and regardless of gender and
menopausal status which are widely known risk factors for
CVD and increased baPWV [21] in apparently healthy Kore-
an adults.
In this investigation subjects were divided into three groups
according to gender and menopausal status because previous
studies had reported the influence of menopause and other con-
ventional atherosclerotic risk factors that accelerate the pro-
gression of atherosclerosis on baPWV [22, 23]. Zaydun et al.
[21] demonstrated a significant relationship between menopause
and baPWV, independent of age and conventional atheroscle-
rotic risk factors. They also suggested oestrogen deficiency
may, at least in part, augment the age-related increase in arte-
rial stiffness during the early postmenopausal phase. In this
study, there were significant differences in atherosclerotic risk
factors, including baPWV, between the premenopausal and
postmenopausal groups (p<0.0001).
Controversy exists as to whether the presence of ELC is
associated with an increased risk of CVD. However, Kaukola
et al. [24] published a comprehensive investigation of the pres-
ence of ELC in CHD to provide additional support for the asso-
ciation. Lichstein et al. [25] showed a significant correlation
between ELC and occlusion of the coronary arteries in an au-
topsy study. Previous researchers suggested that possible mech-
anisms linking ELC and CVD could be the consequences of
systemic loss of elastin and elastic fibre and the aging process.
However, several clinical studies demonstrated the relation-
ship between ELC and CVD independent of age. In the cur-
rent study, ELC was associated with increased baPWV inde-
pendent of age, although a significant association with age was
shown. baPWV is widely used in clinical studies as a surrogate
marker for arterial stiffness and atherosclerotic vascular dam-
age [16, 26]. Increased baPWV is associated with elevated
levels of CHD risk factors. Currently reported data showed
that baPWV may be a non-invasive risk marker of atheroscle-
rotic CVD for the general population [19]. According to the
above results and mechanisms reported in the previous stud-
ies, we may suggest loss of elastin and elastic fibre result in
the development of ELC and increased arterial stiffness mea-
sured by baPWV as shown in the present study. Furthermore,
the results of the present study are in accordance with are con-
sistent with that of the recent study demonstrating ELC was
significantly associated with carotid IMT [4], a marker of sub-
clinical atherosclerosis [6, 7]. The presence of ELC, therefore,
might be an independent surrogate marker of subclinical athe-
rosclerosis in non-hypertensive and non-diabetic adults. To our
knowledge, this is the first report concerning the association
between ELC and baPWV in apparently healthy population.
Nonetheless, there were several limitations to our study.
First, the current study had a cross-sectional design, and there-
fore, causal relationships could not be confirmed. A prospec-
tive study is needed to clarify the causal relationship between
ELC and baPWV. Second, a standard diagnosis of atheroscle-
rosis such as angiography and carotid-femoral PWV were not
performed. Several studies suggested the usefulness of baPWV
as a marker for atherosclerotic vascular damages. However,
baPWV could represent peripheral arterial stiffness as well as
central arterial stiffness even though subjects with self-report-
ed peripheral arterial disease and abnormal Arterial Brachial
Index (ABI) were not included in this study. Third, study sub-
jects consisted of apparently healthy members of the Korean
population with a limited sample size, and therefore, the results
might not be generalisable to all ages, races or individuals with
other disease status. Furthermore, the health promotion centre
at which the current study was conducted is located in down-
town Seoul. Subjects in this study might not be representative
of the general population. Finally, the possible difference, which
remains controversial, between unilateral and bilateral ELC,
the depth of crease, and the length ratio of ELC to earlobe
were not evaluated. Further studies that consider these limi-
tations are needed.
In conclusion, the presence of ELC revealed a significant
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Figure 1. Associations between the presence of ELC and estimat-
ed baPWV in males, premenopausal females, and postmenopausal
females.
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correlation with baPWV independent of other conventional
cardiovascular risk factors in adults aged 20 yr and older.
ELC is an important predictor of increased arterial stiffness
measured by baPWV in asymptomatic subjects in spite of the
limitations of this study. The contribution of ELC-related in-
crease in baPWV to the prognosis of CVD should be further
evaluated before these results can be extrapolated to other
ethnic groups.
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